Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TryptoBPH
2024-519076-75-00Phase 2Suspended
- Sponsor
- Centro Clínico Académico - Braga
- Start
- Nov 2024
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised trial of 5-hydroxytryptophan in benign prostatic hyperplasia (BPH) (2 arms), sponsored by Centro Clínico Académico - Braga. Primary endpoint: Change from baseline in total IPSS score (questions 1–7). Started Nov 2024; status: suspended.
02
Drugs
5-hydroxytryptophan
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on 2024-519076-75-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-519076-75-00.